These are provided in the table below from Q1 of 2020..the last normal quarter before Covid.
As can be seen from the revenue comparison of Q1/20 and Q2/21.......Revenue decline of $22 million .......Covid gave a sh#t kicking to DCM revenues.
Some might argue that CEWS should be removed from statistical comparisions.
I do not agree.
CEWS replaced a portion of what the real fianncial metric would have been in the absence of Covid.
As a consequence, they have been left in.
One time charges of $2.9 m and 2.0 m have been removed from Q1/21 and Q2/21 SGA costs respectively.
These financial revenues show that DCM has performed quite well, despite being taken out behind the shed by Covid.
With lockdowns and other covid restraints removed, DCM ...now lean and mean.. should show an accelerated recovery in revenues and continued gains in key fianncial metrics.
| | | | | | | | |
| Quarter | Revenue | Restruc | Debt | CEWS | Adjusted SGA | Adjusted Ebitda | debt Interest |
| | | | | | | | |
| Q1/20 | 77.4 | 0.7 | 79.4 | 1.6 | 17.3 | 10.5 | 2.1 |
| Q2/20 | 63.9 | 0.3 | 70.1 | 4.6 | 15.5 | 13.5 | 1.9 |
| Q3/20 | 57.4 | 1.1 | 59.9 | 2.8 | 13.3 | 10.2 | 1.8 |
| Q4/20 | 60.6 | 0.7 | 48.2 | 1.8 | 13.0 | 7.4 | 1.5 |
| Q1/21 | 62.4 | 3.4 | 41.1 | 1.9 | 12.6 | 9.3 | 1.2 |
| Q2/21 | 55.4 | 0.95 | 39.1 | 2.4 | 12.9 | 9.3 | 1.1 |
| | | | | | | | |